Navigation Links
Three Healthcare GPOs to Offer Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) to Their Members
Date:3/2/2009

Novation, MedAssets Supply Chain Systems, and Amerinet Also Extend Existing Multi-Year Supplier Agreements

IRVINE, Calif., March 2 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that three of the nation's top hospital Group Purchasing Organizations (GPOs) have established a new Pulse CO-Oximetry(TM) category and extended multi-year supplier agreements for Masimo SET(R) pulse oximetry and Masimo Rainbow SET(R) Pulse CO-Oximetry products. Masimo licenses the technology and supplies Pulse CO-Oximetry products that noninvasively measure multiple blood constituents, which previously required invasive blood drawing procedures.

Establishing a new Pulse CO-Oximetry product category on national contract portfolios allows Novation, MedAssets Supply Chain Systems, and Amerinet to offer an innovative new selection of patient monitoring devices clinically proven to help clinicians provide earlier detection of potentially life-threatening conditions. This enables customer hospitals and healthcare facilities to purchase breakthrough noninvasive blood monitoring products that may increase patient safety, improve the quality of care, and reduce the cost of care at a great value.

Mark Miriani, President, MedAssets Supply Chain Systems, stated: "MedAssets remains focused on the important trends and issues facing the healthcare community and we recognize the importance of providing advanced technology solutions and innovative new product offerings to our customers. Pulse CO-Oximetry has the potential to improve patient safety and clinical performance, thereby delivering greater value to both hospitals and patients. We are proud to be among the first to offer Masimo Rainbow SET Pulse CO-Ox
'/>"/>

SOURCE Masimo Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group
2. Clinipace Recently Awarded $2.8 Million to Manage Three New Clinical Projects
3. 6th Annual World Health Care Congress to Convene Preeminent Leaders for Three Days on Rebuilding Health Care
4. One in Three Cancer Survivors on Unemployment Line
5. Three Miami Physicians and Three Medical Workers Charged With $10 Million Medicare Fraud Scheme
6. Inviro Medical Devices Is Awarded a Three Year Contract with Leading GPO Novation
7. Misonix Reports Earnings and Increased Revenues for the Three and Six Months Ended December 31, 2008
8. Toronto Cosmetic Clinic Offers Axis Three Breast Enlargement Imaging for the First Time in Canada
9. Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party
10. Franklin & Seidelmann Expands into Critical Access Hospital Market Provides 24 x 7 Teleradiology Service for Three New Clients
11. Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Dont Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... , , TUESDAY, Dec. 15 (HealthDay News) -- If that ... on your life that you just can,t wait to have ... you might want to wait at least six months before ... be even better. , The study found that when ... chances of the baby dying, being born prematurely, having birth ...
(Date:12/16/2009)... has received a further 1.6 million Euro in capital funding ... System in order to meet the rapidly growing demand for this ... Unisense A/S that continue to own each about 50% of the ... ... -- Unisense FertiliTech A/S has received a further 1.6 million Euro ...
(Date:12/16/2009)... Request A Test, Ltd. is proud to announce being presented with ... Weatherhead 100 showcases the fastest growing companies in Northeast Ohio and ... to succeed. , ... (PRWEB) December ... being presented with the Weatherhead 100 Upstart Award on December 3, ...
(Date:12/16/2009)... & Ennis, P.A. will continue to offer free nationwide confidential ... serious Paxil side effects such as: Birth Defects, Attempted Suicide, ... can call toll free at 1-800-856-6405 or go to the ... online case evaluation form. , ... ...
(Date:12/15/2009)... developed a new electrophoretic method for detecting MIRCERA ... The technique, using SARCOSYL-PAGE, has specifically enhanced sensitivity ... characteristics of SDS-PAGE for detecting other EPOs. ... from the World Anti-Doping Agency (WADA), appear in ... Analysis published by Wiley-Blackwell. , MIRCERA (methoxy ...
Breaking Medicine News(10 mins):Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3Health News:Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device 2Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Researchers discover novel method for detecting MIRCERA 2
... EL SEGUNDO, Calif., Dec. 27 Computer ... that it has signed an extension to,a ... with Sun Microsystems Inc., Under the ... all,applications development and support services for Sun,s ...
... FDA -, MENLO PARK, Calif., Dec. 27 ... drug-eluting stent (DES),systems, today announced that it has submitted ... Mark approval of its Custom NX DES,System., XTENT,s ... the,drug formulation submission from Biosensors International Group. XTENT,plans to ...
... Dec. 26 Whether it,s living and dying with,every ... the nachos and pizza,that make up the game watching ... of heartburn. Prilosec OTC, the number one selling OTC,heartburn ... opportunity to,win tickets to Super Bowl forty-two in Glendale, ...
... they don,t address benefits of drug therapy , , WEDNESDAY, ... out abnormal heart tissue reduces the number of shocks ... attacks, a new trial showed. , While those shocks ... abnormal rhythms, they are desirable to avoid not only ...
... MELVILLE, N.Y., Dec. 26 Gentiva Health,Services, Inc. (Nasdaq: ... health and related services, announced today that it is,scheduled ... Tuesday, January 8,2008 at the 26th Annual JPMorgan Healthcare ... available to the public via a live audio web ...
... NEW YORK, Dec. 26 Immtech Pharmaceuticals,Inc. (Amex: ... working with clinical,investigators at the South African site ... (DB289), an investigational therapy. In preliminary,findings from the ... following treatment with pafuramidine. The Company has discussed,the ...
Other Medicine News:Health News:CSC Signs Extension to Managed Applications Services Agreement With Sun Microsystems 2Health News:XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe 2Health News:XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe 3Health News:Heart Procedure Reduces Need for Defibrillator Shocks 2Health News:Heart Procedure Reduces Need for Defibrillator Shocks 3Health News:Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco 2Health News:Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco 3Health News:Immtech Announces Pafuramidine (DB289) Program on Clinical Hold 2Health News:Immtech Announces Pafuramidine (DB289) Program on Clinical Hold 3
(Date:12/15/2009)... 15 A Harvard medical expert internationally recognized ... the PGA Tour,s decision last month to suspend ... diagnosed him as having the medical condition ... condition is "unreasonable, unfair and discriminatory." ,, ... normal testosterone levels, often referred to informally as ...
(Date:12/15/2009)... opportune time to find the best plan at the ... Through the end of the year, thousands ... about their health coverage. This is when the ... benefits they will sign up and pay for in ... part of this decision, says Independent Retail Pharmacist Steve ...
(Date:12/15/2009)... Today,s New York Times ... Kidney Drugs Spurs Division," illustrates an internal renal ... patients continuing to be deprived of their life-saving ... limit. ,, As Congress is poised to approve ... lives of transplant kidney recipients, behind-the-scenes debate continues ...
Breaking Medicine Technology:Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2Teen attitudes toward smoking linked to likelihood of drinking and using drugs 58571 1Teen attitudes toward smoking linked to likelihood of drinking and using drugs 58571 2UNC awarded Cancer Genome Atlas grant 10194 1UNC awarded Cancer Genome Atlas grant 10194 2First human gets new antibody aimed at rabies virus 10189 1First human gets new antibody aimed at rabies virus 10189 2First human gets new antibody aimed at rabies virus 10189 3
... DSM N.V., the global Life Sciences and Materials Sciences company ... that DSM Biomedical obtained an exclusive world-wide license for a ... a San Diego based biomedical company. ... up a broad range of opportunities for next generation drug ...
... LOUISVILLE, Colo., March 11 Preliminary findings from a ... Lipo patients shows 40% to 60% tightening. Patients in ... more body areas with the VASER Lipo System. Skin ... measurements have been taken over a 6 month period."Physicians ...
Other Medicine Technology:DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology 2DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology 3DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology 4Research Shows VASER(R) Lipo Results in Excellent Skin Tightening 2
... is a sensitive, simple to ... the detection of all major ... can distinguish between P. ... vivax . In addition, the ...
... is a two site sandwich ... the detection of P. falciparum ... HRP-2) and P. vivax specific ... be used for specific detection ...
The Cellabs Rapimal (P.f.) is a rapid and sensitive in vitro immunochromatography assay system for the detection of HRP-2 antigen produced by P. falciparum at the merozoite (red blood cell) stage o...
An immunochromatographic rapid test for the detection of Plasmodium falciparum in whole blood....
Medicine Products: